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Estrogen, the classical female hormone, is now being investigated to determine its function in male fertility. This has become an increasingly important issue over the past 5 years because data suggest that there has been a progressive increase in disorders of male reproductive development and there is concern as to whether compounds in the environment could have contributed to these adverse changes. Studies have suggested that human sperm counts have declined in some countries according to later year of birth (1) (2) (3) (4) and that the incidence of testicular cancer and some congenital abnormalities (hypospadias and cryptorchidism) have increased in many countries over the same time period (5) (6) (7) (8) (9) . These changes coincide with major changes in lifestyle and with the mass production of synthetic chemicals involved in the production of industrial and domestic commodities (such as pesticides and plastics), some of the ingredients of which have been shown to be weakly estrogenic (xenoestrogens) (10) (11) (12) (13) (14) (15) (16) . As perinatal exposure of male animals and humans to synthetic estrogens can induce similar adverse changes in male reproductive health, it has been hypothesized that inappropriate exposure to estrogens (from inside or outside the body) during critical periods of development may interfere with mechanisms involved in the development of the reproductive system and in determining sperm numbers (17) .
A major obstacle to tackling this issue and defining whether environmental hormone disruptors pose a risk to male reproductive health is the lack of relevant estrogen-regulated end points within the male reproductive system. Recent studies, however, have highlighted the regions of the male reproductive tract that appear to be important sites of estrogen action. One such site is the efferent ducts that join the testis to the initial segment of the epididymis. The efferent ducts comprise a simple epithelium that is composed largely of two cell types (ciliated and nonciliated cells), which normally display a highly columnar appearance. Studies have shown that the efferent ducts express both forms of the estrogen receptor (ER-a and ER-P) (18) and that this region is an important site for the resorption of fluid which enters the efferent ducts along with spermatozoa from the rete testis. This fluid resorption is impaired in transgenic animals lacking a functional ERa receptor, suggesting that estrogens may play a role in fluid resorption (19) .
The lack of relevant estrogen-regulated end points within the male reproductive tract prompted us to assess estrogen exposure using parameters that we have previously identified as being altered after neonatal administration of a high dose (10 pg/injection) of diethylstilbestrol (DES) . Exposure to DES induces gross morphological alterations to the rete testis and efferent ducts (20) . The rete testis becomes grossly enlarged and distended with the distension persisting throughout the efferent ducts. The The selection of doses for the above compounds was based on the following considerations. The highest DES dose was based on our previous studies (20, 21) , and the single dose of ethinyl estradiol tested was selected to be equivalent to this DES dose. The dose and treatment regimen for GnRHa was based on previous studies (21, 22) that showed complete suppression of follicle-stimulating hormone (FSH) levels through to day 18. The doses of bisphenol A and octylphenol were based on maximum solubility of the compounds in oil, and the dose of butyl-parabens was based on recent studies of its effects in vivo on uterine weight in the rat (10) . The Immunocytochemistry. Immunolocalization of AQP-1 was determined using a polyclonal antibody raised to human erythrocyte AQP-1, the validation of which is described elsewhere (20, 25) . The antibody and preimmune serum were used at a dilution of 1:500. Slide-mounted sections were dewaxed in Histoclear (National Diagnostics, Fleet Business Park, Hull, UK), rehydrated through a graded series of ethanol, and washed in distilled water. To block endogenous peroxidase activity, the sections were pretreated with 3% hydrogen peroxide in methanol. Nonspecific binding sites were blocked by incubating the sections in normal swine serum (NSS) diluted 1:5 in Tris-buffered saline (TBS, pH 7.4, containing 50mM Tris-HCI, 150 mM NaCI). The immune and preimmune sera were diluted in the NSS block and 100 pl was added to each slide, which was then coverslipped and incubated overnight in a light-proof box at 40C. After removing the coverslips, the slides were washed in TBS (two times at 5 min each) and then incubated with a linking antibody, biotinylated swine-antirabbit serum (DAKO Ltd., Cambridge, UK; diluted 1:500 in NSS) for 30 min. After two washes in TBS, avidin-biotin conjugated horseradish peroxidase (DAKO) was applied to the slides for 30 min. The slides were given two final rinses in TBS before the addition of a diaminobenzidine (DAB)-based chromogen, which left a brown precipitate at the sites of antibody localization. The slides were developed until the color on control sections reached the required intensity before the reaction was stopped by immersing the slides in distilled water. The slides were then counterstained with hematoxylin, dehydrated by immersion in a graded series of ethanol, and cleared in xylene. A coverslip was fixed over the sections using Pertex mounting medium (Cell Path, Hemel Hempstead, UK).
Evaluation Rete testis and efferent duct morphology.
Tissue sections were prepared as described above and were stained with hematoxylin and eosin. Sections were then viewed under a light microscope to examine the morphology of the efferent ducts and rete testis. Slides were used for analysis of epithelial cell height in the efferent ducts or, where a good cross section of the rete testis had been obtained, the slide was photographed using the system described above. To ensure consistency regarding the cross-section of the rete testis that was photographed, slides were chosen if the region of the rete testis which joins the efferent ducts could be viewed in the plane ofsection.
Efferent duct epithelial cell height. Our previous study (20) demonstrated that neonatal treatment with 10 pg DES altered the shape and height of epithelial cells in the efferent ducts. To evaluate whether similar changes were induced by the present treatments, cross-sections of efferent ducts were evaluated using image analysis from 3-20 rats from the control and treated cohorts at all time points collected. The height of the efferent duct epithelium was measured using an Olympus BH2 microscope fitted with a 40x plan achromat objective and a 3.3x phototube (Olympus Optical). The image was captured using a Sony XC77CE video camera (Sony, Tokyo, Japan) linked to a personal computer with frame grabber and image pro image analyses software (Media Cybernetics, Silver Spring, MD). Using the length tool, we measured the height of the epithelium at right angles from the base of the cell adjacent to the basement membrane to the luminal surface of the cell. After measuring the length, the angle of the line was measured to ensure that it was at 90 degrees. For each animal, we measured at least 50 cells, with sampling from a number of different ducts, and calculated the mean value.
Statistics. We compared testis weights and efferent duct epithelial cell height for control and treated groups at each age point using analysis of variance; where significant differences between groups were indicated, subgroup comparisons utilized the same test, but the overall variance served as the measure of error.
Results
Testis weight after neonatal estrogen exposure. Testis weights were compared between control and treated cohorts at 18, 25, 35, and 75 days of age. Testicular size has previously been shown to be decreased after postnatal exposure to estrogenic compounds (26) and usually provides a gross indication of the total number of cells within each testis. Testis weights were significantly reduced at all ages after treatment with GnRHa, ethinyl estradiol, and all three doses of DES (Fig. 1) 10 in control animals, AQP-1 formed a strong apical band of staining along the brush border of the efferent duct epithelium, as is shown for a control animal at day 18 in Figure 2 . At day 10, when animals injected with 10 pg DES were still undergoing treatment, the efferent ducts had a greatly reduced level of AQP-1 immunoexpression (not shown). In the same group, the efferent duct epithelial cell height appeared noticeably reduced and the efferent duct lumens appeared distended. Treatment with weakly estrogenic compounds (genistein or bisphenol A) caused no detectable reduction in the intensity of AQP-1 immunoexpression or in efferent duct morphology (not shown).
Day 18 . The results ofAQP-1 immunostaining are described in Table 1 , and representative photomicrographs for all treatment groups are shown in Figure 2 . High power oil immersion images are also shown for some treatments in Figure 3 to illustrate more clearly the alterations to the efferent duct epithelium. At day 18 in control rats, AQP-1 immunostaining was clearly evident along the apical brush border of the efferent duct epithelium and along the basolateral surface of the epithelial cells. There was very little immunoreactive AQP-1 along the basal border of the efferent ducts. Similarly, in animals treated with GnRHa, there was strong, apical immunolocalization of AQP-1 to the efferent duct epithelium, the intensity of immunostaining being comparable to control levels. Epithelial cell height in GnRHa-treated rats appeared slightly reduced, but there was no evidence of distension of the efferent duct lumen; indeed, lumens appeared reduced in size in comparison to lumens from control animals (Fig. 2) . In contrast, treatment with potent estrogens (DES 10 jig, 1 Administration ofweakly estrogenic compounds (octylphenol, bisphenol A, and parabens) produced no gross changes in the level of AQP-1 immunostaining, although there was the suggestion of a minor but consistent reduction in immunoexpression after octylphenol treatment (Fig. 2) . The octylphenol group also appeared to have slightly, but consistently, larger lumens in their efferent ducts than did the controls; this was not observed in rats treated neonatally with bisphenol A or parabens. All parameters measured were comparable in genistein-treated and soy-free controls. Individual efferent ducts were examined and photographed under higher power magnification to highlight some ofthe changes described above.
In controls the efferent ducts were composed of a highly columnar, polarized epithelium, with a brush border evident on the apical membrane where AQP-1 immunolocalized. The nuclei of the nonciliated cells are in the basal region of the cell, with the nuclei of ciliated cells in a more central location. The lumen of the duct forms an irregular shape in cross-section. No consistent change to this appearance was evident after neonatal treatment with bisphenol A. In contrast, high dose estrogen treatment (DES or ethinyl estradiol, 10 pg) resulted in alteration of the epithelial cells from a high columnar to a cuboidal shape (Fig. 3) . These cells appeared to lack most of their apical cytoplasm as well as the brush border and its associated immunoexpression of AQP-1. The lumens of the efferent ducts in these animals were much more regular and spheroidal in cross-section (as if turgid) when compared to controls. There was also thickening of the layer of peritubular cells that lie around the outside of the duct. The latter was confirmed by immunohistochemical staining of these cells using an antibody to smooth muscle actin (data not shown). In animals treated with the lowest dose of DES (0.1 jig), we observed efferent ducts that contained epithelial cells with characteristics comparable to control animals, whereas other ducts, which were evident in the same cross-section, displayed morphological characteristics that were similar to those observed after high dose DES treatment (Fig. 3) Figures 4 and 5 , respectively. Day 10. At day 10 in control animals and in rats treated neonatally with weakly estrogenic compounds (genistein and bisphenol A), the epithelium was cuboidallow columnar. In contrast, after neonatal administration of 10 pg DES, the rete testis was grossly distended and the epithelial cells of the rete testis had become flattened and almost squamous in appearance (not shown).
Day 18. In control animals at day 18 (Fig. 4) the epithelium of the rete testis was reduced in height in comparison to animals at day 10, but neonatal treatment with a GnRH antagonist appeared to delay this flattening of the epithelial cells because they still appeared cuboidal, similar to that exhibited by controls on day 10 induced gross distension of the rete testis (Fig. 4) , a change that was not evident in animals treated with 0.1 pg DES. The degree of distension of the rete testis after neonatal exposure to DES appeared to be dose dependent, and the more severe distension was accompanied by deeper invasion of the rete into the testicular parenchyma. Neonatal treatment with weakly estrogenic compounds, octylphenol, bisphenol A, genistein, and butyl-parabens (not shown), had no detectable effect on the morphology of the rete testis (Fig. 4) . Days 25 and 35. In animals assessed at day 25, the gross enlargement of the rete testis was still evident in animals exposed to 10 pg DES (but not at lower doses) or ethinyl estradiol (Table 1) . Similarly, at day 35 signs of fluid retention and distension of the rete testis were only evident in animals treated neonatally with 10 or 1 pg DES (animals treated with ethinyl estradiol were not assessed at this time point).
Day 75. In adulthood there was no sign of abnormal fluid build up or rete testis distension in control (Fig. 5) or GnRHa-treated animals (not shown). However, there were still signs of abnormal distension in animals treated neonatally with DES (10 pg) or ethinyl estradiol, although the severity of these effects was much reduced ( Efferent duct epithelial cell height. The photomicrographs in Figure 3 demonstrate that neonatal estrogen treatment appeared to alter the height of the epithelial cells of the efferent ducts, thus, this was quantified for the various treatment groups at each time point. At day 10, the only time point assessed when rats were still on treatment, there was a significant reduction (p<0.05) in epithelial cell height after administration of 10 pg DES [control = 12.9 ± 1.8 pm (n = 5); DES = 8.6 ± 1.0 (n = 4); mean ± standard deviation (SD)]. There was no change in epithelial cell height after the administration of bisphenol A or genistein on day 10 (data not shown). At day 18, all of the chemicals administered neonatally (except parabens) caused a significant reduction in epithelial cell height (Fig.  6 ). Soy-free control animals had epithelial cell heights that were comparable to the "normal" control population at day 18 (Fig. 6 ) and at later time points (data not shown). Treatment with GnRHa induced a small but significant reduction in efferent duct epithelial cell height at day 18, but was without effect beyond this time point. Administration of the highest dose of DES (10 pg) induced a highly significant reduction in epithelial cell height, which was most severe at postnatal days 18 and 25 postnatal (Fig. 6) . In this group, cell height was still significantly reduced in comparison to control levels at day 35 ; although a small decrease was still evident in adulthood, this did not reach statistical significance. The reduction in epithelial cell height was not as severe after the administration of lower doses of DES (1 and 0.1 pg); by either day 75 (DES 1 pg) or day 35 (DES 0.1 pg), epithelial cell heights had recovered to control levels. Administration of ethinyl estradiol induced a reduction in epithelial cell height which was similar in magnitude to that induced by 10 pg DES at all ages assessed (Fig. 6) . Administration of tamoxifen (assessed only on day 18) induced a significant reduction in epithelial cell height similar to that induced by 0.1-1 pg DES. Octylphenol, bisphenol A, and genistein all induced small but significant reductions in epithelial cell height. However, these changes were transient, and where appropriate time points were collected, no effects were detected beyond day 25 (Fig. 6 ).
Discussion
The efferent ducts are now recognized to be an important site for both fluid resorption and estrogen action within the male reproductive tract (27) . It is also becoming dear that exposure to inappropriate levels of estrogen can induce perturbations in normal fluid dynamics in this region and may have consequences for male fertility. Exposure to high levels of the synthetic estrogen DES in neonatal life has previously been shown to induce gross distension of the rete testis and efferent ducts, as well as reducing the level ofAQP-1 protein expression (20) . Male mice that are homozygous for a mutation in the gene encoding ERa are infertile and show similar changes in fluid dynamics postpubertally (27, 28) . In view of these developments, we assessed whether changes induced to the excurrent duct system of the male might serve as a biological indicator of inappropriate estrogen exposure during development.
In the absence of specific biochemical and molecular markers of estrogen function in the excurrent ducts, we assessed parameters that we previously showed to change after neonatal exposure to DES (20) . We assessed the level of immunoreactive AQP-1 in the efferent duct epithelium and rete testis, we observed efferent duct morphology to assess any signs of distension, and we measured efferent duct epithelial cell height and testis weights from postnatal day 10 until adulthood in animals treated neonatally with estrogenic compounds. As a point of reference, rats were treated with various concentrations (10 pg, 1 pg, 0.1 pg/injection) of the potent synthetic estrogen DES. The effects of DES were compared to those of ethinyl estradiol (10 pg/injection) and tamoxifen and to the effects of weakly estrogenic compounds (bisphenol A, octylphenol, parabens, and the phytoestrogen genistein).
At day 18, neonatal exposure to DES resulted in dose-dependent changes in all of the parameters measured. The greatest effects always occurred after the administration of 10 pg DES, and lesser effects were observed after the administration of the two lower doses (1 and 0.1 pg), although the differences between these two lower doses were sometimes marginal. At time points beyond day 25, dose-dependent effects of DES were still evident on testis weights, and epithelial cell height of the efferent ducts still exhibited dose-dependent changes at days 35 estradiol regarded the more severe distension and overgrowth of the rete testis in the DEStreated cohorts. The overgrowth of the rete testis induced by these potent estrogens may be related to the increased incidence of rete testis adenocarcinoma (normally a rare neoplasm) that has been observed in both humans and mice exposed to DES in utero (30, 31) .
We also addressed the possibility that weakly estrogenic compounds such as phytoestrogens or other xenoestrogens could adversely affect development of the excurrent ducts. The results show that these weak estrogens exert only minor effects on the efferent ducts by marginally and transiently reducing epithelial cell height during puberty. No gross or prolonged changes in the level of immunoexpression of AQP-1, efferent duct distension, or rete testis morphology were detected after the administration of any of these compounds, with the possible exception of octylphenol, which may have caused marginal distension of the efferent ducts at day 18. Due to the transient nature of the effects observed with these chemicals, it is probable that prolonged exposure to very high levels of a weakly estrogenic compound would be required for the persistence of any abnormality in the parameters assessed.
The results in this paper show that neonatal exposure to high levels of estrogen causes deleterious changes in testis weight and other end points. Although these effects persisted long after the cessation of treatment, most of the parameters measured, except for testis weight and rete testis morphology, had largely normalized by 75 days of age. Rete testis morphology still showed signs of distension in both the ethinyl estradiol-and DES (10 pg/injection)-treated animals by 75 days of age, although this parameter is difficult to assess in an objective or quantifiable way. It is also difficult to compare rete testis morphology between animals because cross-sections from identical regions of the tissue must be assessed and only gross changes can be detected easily. Any subtle effects that may have been induced by xenoestrogens therefore would not be detectable. Similarly, it is difficult to detect subtle changes in the level of AQP-1 immunostaining that may have arisen after treatment with weakly estrogenic compounds. Therefore, the most useful parameters measured were efferent duct epithelial cell height and testis weight. Changes in testis weight are very useful to gauge the overall effects of treatment and, in adult animals, testis weight has previously been shown to correlate with daily sperm production (26) . Administration of other compounds, such as GnRHa, produced a similar reduction in testis weight to DES exposure (10 pg/injection), demonstrating that this cannot be used as a specific end point of inappropriate estrogen exposure. The postnatal period is critical for normal testis growth and alterations in Sertoli cell numbers induced at this time point are permanent, whereas other regions of the male reproductive tract appear to be more plastic and showed signs of recovery from estrogenic effects. For example, at 75 days of age, rats treated neonatally with DES (all doses) showed significant reductions in testis weight, whereas efferent duct epithelial cell height was not significantly different from control values. However, efferent duct epithelial cell height is a useful, objective end point for assessing both gross and subtle effects of estrogenic compounds at earlier time points in development and can also be used to monitor the duration of these effects. Although the parameters assessed in the present study together give a strong indication of effects induced by estrogenic chemicals on the reproductive tract, the specificity of these effects remains to be established: Can compounds that are not estrogenic induce similar changes?
The present findings add to recent data (20, 27) which suggest that the excurrent ducts and, in particular, the efferent ducts are important physiological sites of estrogen action. Other data suggest that estrogens play a central role in regulating fluid resorption from around the sperm as they travel from the testis to the epididymis (32, 33) . Of the fluid that enters the efferent ducts from the testis, 96.2% is resorbed before reaching the epididymis, along with most inorganic electrolytes and proteins (32) . Many factors known to be involved in ion and water movement (e.g., Na+-K+ ATPase, Na+-H+, and Cl-HCO3 exchangers and Na+-K+-2C[3 symport) (34) (35) (36) have been localized to the efferent ducts, but as yet there is no information as to which, if any, of these ion channels are estrogen regulated. A good candidate molecule is a member of the ABC transporter family, which is involved in the pathology that arises in individuals with inactivating mutations in the cystic fibrosis (CF) gene. The cystic fibrosis transmembrane regulator (CFTR) is a cAMP-activated Cl-channel. It is well established that patients with CF are often infertile due to degeneration of the vas deferens, but some also suffer from obstructive azoospermia due to the deposition of thick mucous material in the epididymal lumen (37, 38) . There is evidence that a cAMP-activated C1-channel exists in the epididymal epithelium (39, 40) . Also, in situ hybridization studies on human tissue have localized the mRNA of this protein to the epididymis and vas deferens, with the highest expression in the head of the epididymis (41) , raising the likelihood of its expression also in the efferent ducts. CFTR may be a good candidate for hormonal regulation because studies on female rats have shown that estrogen up regulates its expression in the uterine epithelium (42, 43) . In addition, both CF mutations and increased estradiol levels have been found in otherwise healthy men with reduced sperm quality (37, 44) .
It will be important in future studies to establish which components of the fluid endocytosis pathway in efferent ducts are estrogen regulated because this may provide a more direct and quantifiable end point of estrogen exposure that can be applied to studies of the effects of environmental and other estrogens on development and function of the male reproductive system.
